Worldwide Prostate Cancer Industry to 2024 - Rising Public Awareness towards Prostate Cancer Treatment is Driving Growth
DUBLIN, Dec. 7, 2020 /PRNewswire/ -- The "Global Prostate Cancer Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
This report provides a detailed analysis of the global prostate cancer market with description of market sizing and growth. The analysis includes market by value, by volume, by country and by drugs. Furthermore, the report also provides detailed drug and regional analysis.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall global prostate cancer market has also been forecasted for the years 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global prostate cancer market is consolidated as the majority of market share is captured by major players of the market. Some of the key players operating in the global prostate cancer market, whose company profiling has been done in the report are Pfizer Inc., Johnson & Johnson, Bayer AG, and AstraZeneca. This segment of the report provides business overview, financial overview and business strategies of the respective companies.
Region Coverage
- The US
- China
The global prostate cancer market has shown tremendous growth over the past few years and projections are made that the market would grow at a rapid pace over the forecasted period (2020-2024) as well. The aging population and altering lifestyle are the major factors contributed in the growth of market. Moreover, expanding healthcare cost, rising public awareness towards the disease, availability of generic drugs etc. would further augment market growth.
However, the market faces some challenges which are hindering the growth. Some of the major challenges faced by the industry are increasing economic burden of the disease, side-effects associated with treatment, over diagnosis issue etc. Though, the market growth would be further supported by various market trends like increasing use of diverse therapies, approval of novel treatments and drugs, advancements in prostate cancer research etc.
Key Topics Covered:
1. Executive Summary
2. Introduction
2.1 Cancer: An Overview
2.1.1 Introduction
2.1.2 Types of Cancer
2.2 Prostate Cancer: An Overview
2.2.1 Introduction
2.2.2 Prostate Cancer Symptoms
2.2.3 Stages of Prostate Cancer
2.2.4 Types of Prostate Cancer
2.2.5 Treatments Available
3. Global Market Analysis
3.1 Global Prostate Cancer Market: An Analysis
3.1.1 Global Prostate Cancer Drug Market by Value
3.1.2 Global Prostate Cancer Drug Market by Country (US, China, ROW)
3.1.3 Global Prostate Cancer Market by Drugs (Enzalutamide, Abiraterone acetate, Leuprorelin, Goserelin, Cabazitaxel, Bicalutamide, Radium 223 dichloride, others)
3.2 Global Prostate Cancer Market: Drug Analysis
3.2.1 Global Enzalutamide Market by Value
3.2.2 Global Abiraterone acetate Market by Value
3.2.3 Global Leuprorelin Market by Value
3.2.4 Global Goserelin Market by Value
3.2.5 Global Cabazitaxel Market by Value
3.2.6 Global Bicalutamide Market by Value
3.2.7 Global Radium 223 dicholoride Market by Value
3.2.8 Global Prostate Cancer Others Drug Market by Value
4. Regional Market Analysis
4.1 The US Prostate Cancer Market: An Analysis
4.1.1 The US Prostate Cancer Drug Market by Value
4.1.2 The US Prostate Cancer Market by Drug (Enzalutamide, Abiraterone acetate, Leuprorelin, Radium 223 dichloride, others)
4.1.3 The US Prostate Cancer Market by Volume
4.1.4 The US mCRPC Market by Volume
4.1.5 The US Prostate Cancer Second-Line Therapies Market by Volume
4.2 The US Prostate Cancer Market: Drug Analysis
4.2.1 The US Enzalutamide Market by Value
4.2.2 The US Abiraterone acetate Market by Value
4.2.3 The US Leuprorelin Market by Value
4.2.4 The US Radium 223 dichloride Market by Value
4.2.5 The US Cabazitaxel Market by Value
4.2.6 The US Prostate Cancer Others Drug Market by Value
4.3 China Prostate Cancer Market: An Analysis
4.3.1 China Prostate Cancer Drug Market by Value
4.3.2 China Prostate Cancer Market by Drug (Abiraterone acetate, Bicalutamide, Docetaxel, Leuprorelin, Goserelin, Triptorelin, Others)
4.3.3 China Prostate Cancer Market by Volume
4.3.4 China mCRPC Market by Volume
4.3.5 China mCRPC First-Line Treatment Market by Value
4.3.6 China mCRPC Second-Line Treatment Market by Value
4.3.7 China Prostate Cancer Second Line Therapies Market by Volume
4.4 China Prostate Cancer Market: Drug Analysis
4.4.1 China Abiraterone acetate Market by Value
4.4.2 China Bicalutamide Market by Value
4.4.3 China Docetaxel Market by Value
4.4.4 China Leuprorelin Market by Value
4.4.5 China Goserelin Market by Value
4.4.6 China Triptorelin Market by Value
4.4.7 China Prostate Cancer Other Drugs Market by Value
5. COVID-19
5.1 Impact of Covid-19 on Healthcare Industry
5.2 Impact of COVID-19 on Cancer Treatment
5.3 Impact of COVID-19 on Prostate Cancer Treatment
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increase in Prevalence of Prostate Cancer
6.1.2 Rise in Geriatric Population
6.1.3 Expanding Healthcare Costs
6.1.4 Rising Public Awareness towards Prostate Cancer Treatment
6.1.5 Altering Lifestyle
6.1.6 Availability of Generic Drugs
6.2 Challenges
6.2.1 Increasing Economic Burden of the Disease
6.2.2 Side-Effects Associated with Treatment
6.2.3 Overdiagnosis Issue
6.2.4 Loss of Patent Protection of Drugs
6.3 Market Trends
6.3.1 Increasing Use of Diverse Therapies
6.3.2 Approval of Novel Treatments and Drugs
6.3.3 Advances in Prostate Cancer Research
7. Competitive Landscape
7.1 The US Prostate Cancer Players' Product Comparison
7.2 The US Prostate Cancer (mCRPC) Players' Product Comparison
7.3 China Prostate Cancer Players' Product Comparison
7.4 China Prostate Cancer (mCRPC) Players' Product Comparison
7.5 China Other Types Prostate Cancer Players' Product Comparison
7.6 mCRPC Drugs Clinical Trial Results Comparison
8. Company Profiles
8.1 Pfizer Inc.
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Johnson & Johnson
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Bayer AG
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 AstraZeneca
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
For more information about this report visit https://www.researchandmarkets.com/r/4auqel
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article